Variant report
Variant | esv3409359 |
---|---|
Chromosome Location | chr10:54593321-54596094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10824813 | chr10:54595602-54595603 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs184836376 | chr10:54595650-54595651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs571699790 | chr10:54595680-54595681 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs56141225 | chr10:54595681-54595682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs565140521 | chr10:54595693-54595694 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555826873 | chr10:54595721-54595722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572403013 | chr10:54595723-54595724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34990659 | chr10:54595789-54595790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs551117799 | chr10:54595798-54595799 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs372733946 | chr10:54595801-54595802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs189147376 | chr10:54595809-54595810 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs541523402 | chr10:54595822-54595823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs534213549 | chr10:54595840-54595841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs564288091 | chr10:54595852-54595853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs533184122 | chr10:54595853-54595854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs545678497 | chr10:54595866-54595867 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554205691 | chr10:54595890-54595891 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs562482909 | chr10:54595900-54595901 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145156541 | chr10:54595928-54595929 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs548035264 | chr10:54595960-54595961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567609438 | chr10:54595963-54595964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568258510 | chr10:54595969-54595970 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs527364152 | chr10:54596001-54596002 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs369562795 | chr10:54596004-54596005 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs547493600 | chr10:54596008-54596009 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10824814 | chr10:54596025-54596026 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs539473203 | chr10:54596034-54596035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147580472 | chr10:54596052-54596053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs556329106 | chr10:54596058-54596059 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570406442 | chr10:54596075-54596076 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs576120251 | chr10:54596081-54596082 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Dysmorphic features | 21948486 | CNVD |
Epilepsy | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:54595600-54596400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |